Showing results (1041-1050 of 1,132) with videos related to

Sort By:
Pageof 114
Cancer Research|March 5, 2015
CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapyJemima Escamilla, Shiruyeh Schokrpur, Connie Liu, et al.
The Journal of Urology|July 3, 2020
Impact of Time to Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell CarcinomaBenjamin Shiff, Rodney H Breau, Premal Patel, et al.
Biomaterials|July 26, 2021
Comparative immunogenicity of decellularized wild type and alpha 1,3 galactosyltransferase knockout pig lungsNathan Gasek, Jacob Dearborn, Sara Rolandsson Enes, et al.
The Journal of Urology|December 21, 2020
Hypothermia During Partial Nephrectomy for Patients with Renal Tumors: A Randomized Controlled TrialRodney H Breau, Dean A Fergusson, Greg Knoll, et al.
Japanese Journal of Clinical Oncology|October 29, 2025
Cemiplimab in Japanese patients with advanced non-small cell lung cancerYuki Sato, Yoko Tani, Hidenobu Ishii, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2024
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer with PD-L1 ≥ 1 %: A subgroup analysis from the EMPOWER-Lung 3 part 2 trialAna Baramidze, Tamta Makharadze, Miranda Gogishvili, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2026
131I-LNTH-1095 Radioligand Therapy Plus Enzalutamide vs. Enzalutamide Alone in Men With PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase 2 StudyEvan Y Yu, Vivek Narayan, Giuseppe Esposito, et al.
The Journal of Urology|February 26, 2021
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY)Kenneth J Pienta, Michael A Gorin, Steven P Rowe, et al.
Molecular Oncology|April 22, 2023
Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancerKevin Gonthier, Cindy Weidmann, Line Berthiaume, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 31, 2023
Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 TrialTamta Makharadze, Miranda Gogishvili, Tamar Melkadze, et al.
Pageof 114